Cargando…

Evaluation of the Role of SNCA Variants in Survival without Neurological Disease

BACKGROUND: A variety of definitions of successful aging have been proposed, many of which relate to longevity, freedom from disease and disability, or preservation of high physical and cognitive function. Many behavioral, biomedical, and psychological factors have been linked with these various mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heckman, Michael G., Soto-Ortolaza, Alexandra I., Diehl, Nancy N., Carrasquillo, Minerva M., Uitti, Ryan J., Wszolek, Zbigniew K., Graff-Radford, Neill R., Ross, Owen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418246/ https://www.ncbi.nlm.nih.gov/pubmed/22912757 http://dx.doi.org/10.1371/journal.pone.0042877

Ejemplares similares

Analysis of COQ2 gene in multiple system atrophy
por: Ogaki, Kotaro, et al.
Publicado: (2014)

Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson’s Disease Locus
por: Labbé, Catherine, et al.
Publicado: (2015)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

Genetic architecture of Parkinson’s disease subtypes – Review of the literature
por: Dulski, Jarosław, et al.
Publicado: (2022)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease
por: Deutschlander, Angela B., et al.
Publicado: (2020)

NOTCH3 Variants and Risk of Ischemic Stroke
por: Ross, Owen A., et al.
Publicado: (2013)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies
por: Walton, Ronald L., et al.
Publicado: (2016)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020)

Analysis of Nuclear Export Sequence Regions of FUS-Related RNA-Binding Proteins in Essential Tremor
por: Lorenzo-Betancor, Oswaldo, et al.
Publicado: (2014)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci
por: Sanchez-Contreras, Monica Y., et al.
Publicado: (2018)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
por: Li, Yuanyuan, et al.
Publicado: (2017)

Clinical and pathologic features of cognitive-predominant corticobasal degeneration
por: Sakae, Nobutaka, et al.
Publicado: (2020)

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease
por: Guo, Yi, et al.
Publicado: (2021)

SNCA 3′ UTR Genetic Variants in Patients with Parkinson’s Disease
por: Blažeković, Antonela, et al.
Publicado: (2021)

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
por: Allen, Mariet, et al.
Publicado: (2012)

Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy
por: Al-Chalabi, Ammar, et al.
Publicado: (2009)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures
por: Valentino, Rebecca R., et al.
Publicado: (2022)

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
por: Bras, Jose, et al.
Publicado: (2014)

MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features
por: Valentino, Rebecca R., et al.
Publicado: (2020)

SNCA-AS1 in aging and Parkinson’s disease
por: Carelli, Stephana, et al.
Publicado: (2022)

Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test
por: Ferman, Tanis J, et al.
Publicado: (2014)

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
por: Cooper, Christine A., et al.
Publicado: (2016)

Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review
por: Campêlo, Clarissa Loureiro das Chagas, et al.
Publicado: (2017)

Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease
por: Hou, Xu, et al.
Publicado: (2018)

Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology
por: Zou, Fanggeng, et al.
Publicado: (2013)

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

CWH43 Variants Are Associated With Disease Risk and Clinical Phenotypic Measures in Patients With Normal Pressure Hydrocephalus
por: Tipton, Philip W., et al.
Publicado: (2023)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Variants in SNCA Gene Are Associated with Parkinson’s Disease Risk and Cognitive Symptoms in a Brazilian Sample
por: Campêlo, Clarissa L.C, et al.
Publicado: (2017)

A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
por: Pedersen, Camilla Christina, et al.
Publicado: (2021)

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
por: Carrasquillo, Minerva M, et al.
Publicado: (2011)

Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
por: Kiely, Aoife P., et al.
Publicado: (2015)

The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer’s disease: A cross-sectional study
por: Matchett, Billie J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s9vk54u7dondbkoafbu4td4661